SBIR/STTR Research Award
A rapid, accurate, and easy-to-use diagnostic assay for STIs
Award amount
$224,899Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AI BIOSCIENCES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- J4S6VXC9CK77
- Solicitation number
- PA13-234
- Topic code
- NIAID
Research abstract
DESCRIPTION (provided by applicant): The aim of this application is to develop a rapid, easy-to-use, and inexpensive multi-sample diagnostic system to identify sexually transmitted infection (STI) pathogens, such as Chlamydia trachomatis (CT) and Neisseriagonorrhoeae (NG) in non-traditional healthcare settings. According to the CDC, chlamydia and gonorrhea, caused by C. trachomatis and N. gonorrhoeae, respectively, are the first and second most frequently reported STIs in the US and likely the rest of theworld. These STIs are often under-diagnosed, leading to delayed treatment, continued spread and higher public healthcare costs (~ 16 billion annually). As a result of their prevalence and long term health consequences, there is a need for rapid, sensitivemethods of detecting STIs in order for patients to get results and treatment immediately. It is important that patients receive results and initial consultation or treatment during the first patient visit, as they rarely return for a second visit. Poi
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Self-Contained Dual-Mode Sample Preparation Module Using Non-Hazardous Reagents
- RAPID RT-LAMP ASSAY FOR SELF-MONITORING OF ACUTE OR REBOUND HIV-1 INFECTION USING FINGER-PRICK WHOLE BLOOD SAMPLE AND RNA EXTRACTION
- A Microgravity-Compatible Liquid-Free Surface Sampling Pen (SSP)
- Self-Contained Dual-Mode Sample Preparation Module Using Non-Hazardous Reagents
- An Ultrasensitive and Low-Cost p24 Antigen Test for the Early Detection of HIV
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
22 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $6,854,707. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Aeronautics and Space Administration